Thursday, July 28, 2011


An interesting study in the American Journal of Clinical Nutrition about sleep deprivation and calorie consumption. Thirty men and women in their 30's and 40's, all of about normal weight, lived and slept in a research center during 2 different 5-night periods. During one of the visits, participants were allowed to sleep 9 hours each night. During the other 5-night visit, the participants were only allowed to sleep 4 hours per night. During both 5-night periods, they were fed strict diets for the first four days, then allowed to eat whatever they wanted on the fifth day.

The results showed that regardless of the sleep schedule they were on, the participants burned a similar amount of calories, about 2600 calories per day. In those that slept only four hours, they fed themselves about 300 more calories on average on that final day than when they slept 9 hours.

The researchers propose that sleep is involved in how your body manages hormones that are involved in hunger and food choices when you're hungry. The difference between 9 and 4 hours is dramatic, and I wonder if people would eat more calories if they got 5, 6, 7, or 8 hours of sleep? More studies are needed to answer this and other questions about the relationsip between sleep, sleep deprivation, and obesity.

A New Way to Control Pressure in CPAP for Obstructive Sleep Apnea

In the June edition of the Journal of Clinical Sleep Medicine is an article about Fisher & Paykel's SensAwake system. The authors describe how long-term compliance with CPAP varies from 29 to 83%. One of the factors that affects usage is perception of excessive pressure. Many of the new CPAPs have a comfort feature that allows the user to ramp the pressure up from the lowest setting to the prescribed pressure over a certain number of minutes. If a patient wakes in the middle of night, however, they would have to reach over and activate the CPAP ramp again. The SensAwake system allows the CPAP machine to evaluate the breathing patterns of a CPAP user while it is being worn. If the SensAwake CPAP detects a breathing pattern characteristic of being awake, then it automatically lowers the pressure. This will prevent the patient from having to lower the pressure with the ramp manually. The SensAwake will then automatically increase the pressure once it detects breathing patterns consistent with sleep. Thus, SensAwake might reduce the time a patient is awake at night with the CPAP on.

The hope is that the SensAwake will make the CPAP pressure more comfortable (and possibly lower) if and when the user wakes up in the middle of the night. In the study, 42 patients were randomly selected to wear either a regular CPAP or one with SensAwake for the first night in the lab. On the second night in the lab, the patient wore the other type of CPAP. The results showed that there was no difference in the amount of time patients spent awake at night, no difference in the stages of their sleep, and no difference in the patients' perception of therapy between the regular CPAP and the SensAwake one.

These results are not surprising. In my experience, when the overwhelming majority of patients wake in the middle of the night with their CPAP on, they do not complain of the pressure being too high - they report that they can't even tell if the CPAP is on because they have acclimated to the pressure while asleep. Also, a significant amount of patients don't like the ramp feature after they have worn a CPAP for several weeks. So I imagine the SensAwake feature might disturb those patients as well, since it automatically activates the ramp feature.

To be fair to the SensAwake system, this study only measured one night's effects. We need long-term studies to determine its effect on long-term compliance.

Monday, July 25, 2011

Insomnia, Western Medicine, and India

I saw an article in Reuters Health about drug companies pushing western medications in countries like Inida. The article was in reference to a newspaper ad published in India by the pharmaceutical company Abbott. The ad does not mention the drug Abbott makes, but uses a research finding to draw attention to insomnia by "scaring" consumers.

The ad says "research shows that sleeping less than 6 hours per night leads to a 48% increase in developing or dying from heart disease." This research is from a real study, but the underlying message implies that sleeping 6 or more hours will protect from heart disease - which is not necessarily true. There is a link on the ad to a website featuring Abbott's insomnia drug, Zolfresh, which is the same as Ambien. The concern is that this ad will drive demand for insomnia medications, with Indian consumers thinking they may protect their heart if they take a sleeping pill. This isn't necessarily true, as there are several studies showing an increased mortality rate for those taking sleeping pills, even when controlling for other medical diseases.

Apparently, incomes are rising, insurance coverage is expanding, and there is more chronic disease among people of India. This translates into a large, untapped market for pharmaceutical companies. The companies say they are raising awareness of disease and illness by running these ads - perhaps they are. However, on the ad in question, there is no mention of behavioral treatment for insomnia - which would be the preferred treatment modality by most sleep physicians. There are 10 questions that consumers can answer about their sleep. If they answer positive to just one of those, the ad suggests you talk to your doctor. I guess that's a good thing, as long as that doctor is able to do a thorough sleep assessment or refer those patients to sleep physicians.

Thursday, July 21, 2011

Nasal Masks vs. Full-Face Masks During CPAP Titrations

In the July edition of the Sleep Journal is an article about using different types of CPAP masks during CPAP calibration studies. Currently most patients with suspected obstructive sleep apnea (OSA) have the diagnosis confirmed by a sleep study. If that patient will be using CPAP for treatment, than usually the patient spends a second night in the sleep lab to have the CPAP calibrated (or titrated) to the optimal settings while the patient is asleep. During this titration study, the mask(s) used can make a big difference. But, as the study authors point out, there are few studies done to help sleep technologists decide which type of mask to use on the titration study - over the nose (nasal) or over the nose and mouth (FFM) mask.

In this study, researchers randomly assigned 24 patients with OSA to two separate titration nights - one with the nasal mask and the other with the FFM. For the nasal mask titrations, the researchers had the patient wear a chin strap to keep the patient's mouth from opening which would prevent mouth leak. These patients were titrated using "smart" CPAP machines in the lab, which are capable of finding the optimal pressure settings automatically. In other words, these patients' CPAP's were not calibrated manually, as is the standard. This was on purpose to minimize human variability. The final pressure determination though was chosen by a sleep physician after they reviewed the titration study.

The results showed that the optimal pressure chosen by the sleep physician was no different for the nasal vs the FFM. Also, the automatic CPAP chose similar pressures whether it was a nasal or FFM. Fifty-four percent of patients had pressure differences that were less than 2 cm whereas 46% had pressure differences of 2 cm or greater between the two mask types.

Patients also rated nasal masks as better fitting and more comfortable than FFM, which has been my clinical experience. Perceived sleep quality was not different for the nasal mask vs FFM. Titrations done with the FFM, compared to the nasal mask, did have increased mask leak, more mouth dryness, increased residual respiratory disturbance and arousal indexes, decreased slow wave sleep, and decreased total amount of total sleep time on the titration night.

The results of this study support using nasal masks rather than FFM for titration studies. This has been my experience as well. Sometimes, sleep technologists have to use a FFM because the patient has persistent mouth leak on a nasal mask, even with the chin strap. Using the best type of mask may improve CPAP compliance as patients early experiences with CPAP tend to predict long-term usage.

Tuesday, July 19, 2011

Sleep-Disordered Breathing and Polycystic Ovarian Syndrome

An interesting abstract in the Journal of Pediatrics about polycystic ovarian syndrome (PCOS). PCOS is an endocrine disorder that affects the ovaries and produces menstrual abnormalities, excess male hormones, and elevated weight. Since many girls with PCOS are overweight, they are at increased risk of sleep-disordered breathing (SDB) like obstructive sleep apnea, excessive daytime sleepiness (EDS), and the metabolic syndrome.

Researchers studied 103 girls with PCOS and 90 controls, all ages 13-18 years old. Both groups were matched by age, ethnicity, and body mass index (BMI). The results showed that SDB occurred in 46% of the girls with PCOS versus 28% in controls. EDS occurred in 54% of girls with PCOS versus 36% of controls. The metabolic syndrome occured in 43% of girls with PCOS versus 16% of controls.

This means that girls with PCOS have a higher risk of having SDB and EDS than girls without PCOS, regardless of obesity. The researchers suggest that patients diagnosed with PCOS be referred to sleep physicians if they exhibit EDS or other sleep disturbances.

Saturday, July 16, 2011

Better Sleep and Daytime Functioning When Parents Set Bedtimes in Adolescents

There is an interesting article in the June edition of the Sleep Journal about parents setting bedtimes for adolescents, and the impact this can have on sleep and daytime functioning. Many adolescents are sleep-deprived these days due to early school start times, need to complete homework, after school activities like work and sports, and of course, smart phones / TV / video games in the bedroom.

Researchers surveyed 385 adolescents aged 13-18 years old, and 17.5% of them said their parents set their bedtime. Naturally, this was an age dependent finding, with more younger children reporting parent-set bedtimes than older children. But the interesting part was that those children that had parent-set bedtimes went to bed 23 minutes earlier, slept 19 minutes more on school nights, reported less datyime fatigue, and had less trouble staying awake during the day. There was no difference in the reported time it took to fall asleep, whether the parent or adolescent set the bedtime.

The researchers concluded that the findings from this study support the potential benefit of parent limit-setting around bedtimes for adolescents. Of note, the differences in sleep parameters disappeared on the weekends, when parents did not set bedtimes for the adolescents. This further strengthens the positive effect that the parent-set bedtimes had on sleep.

Possible Mechanisms of Central Apneas in Obstructive Sleep Apnea Syndrome

An article in the June edition of the Sleep Journal is about the different types of apneas seen in patients with obstructive sleep apnea syndrome (OSA). This post is going to be on the technical side, so reader beware. There are two main types of apneas. Obstructive ones are the more common type, and occur when the upper airway (or throat) collapse. Central apneas occur when the throat remains open, but there is no breath due to a communication problem between the brain and lungs. An analogy might help explain it better. Imagine our respiratory system is like a garden hose attached to a spigot. If you turn the spigot on, but pinch off the hose, you get little or no water flow - that is like an obstructive apnea. If you turn off the spigot, but leave the hose alone, you get no water flow - that is like a central apnea.

In OSA, patients usually have mostly obstructive apneas, but can occasionally have central ones as well. Researchers are not clear why this occurs. There is speculation that in patients with both types of apneas, there are at least two mechanisms in place. One is that the throats of these patients collapse more easily than individuals without OSA - this leads to the obstructive apneas. The second is that there is an instability in the control of breathing in patients with OSA. What this means is that the brain likes to have a precise level of carbon dioxide (CO2) in the blood - if it gets too high, your brain will make you breathe harder and faster to bring down the CO2 level. If the CO2 level gets too low, your brain makes you breathe less or even not at all to allow the CO2 level to rise up to normal. If you have an obstructive apnea, your lungs are still trying to breathe, but can't due to the closed throat. After the obstructive apnea is over, however, some people's brain overcompensates and breathes too hard and too fast. This reduces the CO2 level and the brain reduces breathing rates to make the CO2 level rise - this compensation can lead to the central apneas seen in OSA.

In this study, researchers studied the differences between patients with OSA that had pure obstructive apneas and no central apneas, and those with predominant obstructive apneas but with some degree of central apneas. Using sophisticated tools, they determined that patients with predominant OSA had more respiratory control instability than those that had pure OSA. In other words, the patients with predominant OSA were more likely to have their spigots turned off. Both groups had the same upper airway collapsibility, so that does not explain why the predominent OSA group has central apneas. These findings could help researchers figure out ways to treat patients that have non-obstructive apneas as part of their OSA syndrome.